Chicago, IL 的 免疫系統與疾病 臨床試驗
8 項針對 免疫系統與疾病 的研究正在 Chicago（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
招募中觀察性研究
- Swedish Covenant Hospital, Chicago
- Advocate Illinois Masonic Medical Center, Chicago
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
招募中1/2 期
- University of Illinois Hospital & Health Sciences System, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
招募中1/2 期
- University of Chicago Medical Center, Chicago
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
招募中1/2 期
- Northwestern University, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- Northwestern Memorial Hospital, Chicago
Study of Gastric Motility in Eosinophilic Gastritis
招募中觀察性研究
- Northwestern University, Chicago
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
招募中2 期
- University of Illinois Medical Center - Hematology & Oncology, Chicago
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
招募中4 期
- University of Chicago, Chicago
其他城市的 免疫系統與疾病 試驗
- Washington, DC13 項研究
- New York City, NY12 項研究
- Boston, MA10 項研究
- Philadelphia, PA10 項研究
- Atlanta, GA9 項研究
- Portland, OR9 項研究
- Houston, TX9 項研究
- Cleveland, OH8 項研究
- Los Angeles, CA8 項研究
- Milwaukee, WI6 項研究
- Seattle, WA6 項研究
- Cedar Rapids, IA6 項研究
Chicago 的其他研究
- 非小細胞肺癌61 項研究
- 乳癌58 項研究
- 癌症（所有類型）51 項研究
- 轉移性癌症45 項研究
- 前列腺癌45 項研究
- 肥胖症41 項研究
- 肺癌41 項研究
- 卵巢癌36 項研究
- 中風34 項研究
- 大腸直腸癌33 項研究
- 心臟衰竭31 項研究
- 過重28 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。